Arcturus Therapeutics In...
(ARCT)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -29.73M | 9.35M | -203.67M | -72.15M | -25.99M | -21.79M | -10.90M | -24.60M | -19.45M | -32.83M | -10.55M | -1.58M | -3.93M |
| Depreciation & Amortization | 2.96M | 1.53M | 1.19M | 882.00K | 684.00K | 582.00K | 410.00K | 61.00K | 51.00K | 31.00K | 8.00K | 7.00K | 6.00K |
| Stock-Based Compensation | 34.65M | 30.61M | 28.91M | 6.76M | 1.98M | 1.26M | 2.17M | 2.50M | 2.37M | 4.09M | 1.54M | 26.00K | 1.55M |
| Other Working Capital | 38.92M | -10.05M | 32.79M | 7.04M | 8.97M | 159.00K | 6.05M | 2.21M | -867.00K | 130.00K | 1.42M | 12.00K | -86.00K |
| Other Non-Cash Items | -33.36M | 3.06M | 8.38M | 162.00K | 873.00K | 38.00K | 498.00K | 123.00K | 2.37M | 4.09M | 203.00K | 62.00K | - |
| Deferred Income Tax | - | - | -1.09M | 263.00K | 25.00K | 302.00K | - | - | -2.37M | -4.09M | 1K | - | - |
| Change in Working Capital | 7.38M | -12.56M | 31.23M | 21.22M | 15.98M | -1.16M | 7.36M | 2.68M | -1.11M | 388.00K | 1.44M | -101.00K | 9.00K |
| Operating Cash Flow | -18.10M | 31.99M | -135.04M | -42.86M | -6.45M | -20.76M | -460.00K | -19.24M | -18.15M | -28.33M | -7.35M | -1.58M | -2.36M |
| Capital Expenditures | -2.90M | -7.73M | -3.41M | -1.74M | -818.00K | -1.48M | -251.00K | -74.00K | -181.00K | -79.00K | -39.00K | - | -24.00K |
| Acquisitions | - | - | - | - | - | - | 29.00K | -20.02M | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | -6.59M | - | -17.37M | -33.50M | - | -28.01M | - | -517.00K |
| Sales Maturities Of Investments | - | - | - | - | - | 30.21M | 10.58M | 22.33M | - | 8.49M | - | 519.00K | - |
| Other Investing Acitivies | - | -8.30M | -3.46M | -1.74M | -1.06M | 23.61M | 29.00K | 20.02M | -161.00K | 8.49M | -28.01M | 507.00K | -500.00K |
| Investing Cash Flow | -2.90M | -7.73M | -3.41M | -1.74M | -818.00K | 22.13M | 10.36M | 4.88M | -33.84M | 8.41M | -28.05M | 1.03M | -1.04M |
| Debt Repayment | -27.36M | -5.00M | 46.60M | - | 4.95M | 9.87M | 5.65M | - | 1.89M | - | 115.00K | 600.00K | 450.00K |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 2.67M | 1.73M | 902.00K | 12.33M | 15.68M | 332.00K | 1.35M | 6.00K | -66.44M | - | 29.00K | - | - |
| Financial Cash Flow | -24.09M | -2.86M | 48.02M | 436.14M | 41.91M | 10.20M | 7.00M | 6.00K | 66.47M | - | 57.40M | 601.00K | 2.62M |
| Net Cash Flow | -45.09M | 21.41M | -90.43M | 391.54M | 34.64M | 11.58M | 16.89M | -14.35M | 14.48M | -19.92M | 22.00M | 42.00K | -782.00K |
| Free Cash Flow | -21.00M | 24.27M | -138.45M | -44.60M | -7.26M | -22.24M | -711.00K | -19.32M | -18.33M | -28.41M | -7.39M | -1.58M | -2.38M |